APC and intestinal neoplasm: Moreover, a chemical compound that inhibits both IGF‐1 and STAT3 signaling has been reported to reduce intestinal tumor burden induced by Apc deletion by affecting several stromal cells (Sanchez‐Lopez et al, 2016).